Grant

A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Evaluating the Safety and Effectiveness of the MOTIV Sirolimus-Eluting Bioresorbable Vascular Scaffold Compared with Plain Balloo

Sponsored by REVA Medical, LLC

Active

$331.6K Funding

3 People

External

Related Topics

clinical trial, cardiology, bioresorbable scaffold, sirolimus-eluting, vascular intervention

People

Gustavo Cornejo
(CD)
Senior VP Health Sciences﹒Research Compliance Administrator II
Melissa Ruiz
(CD)
Medical Imaging﹒Clinical Research Coordinator I
Kirsten Anderson
(CD)
Senior VP Health Sciences﹒Research Compliance Administrator IV